Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
This piece explains how to spot funds with the lowest tax drag to improve retirement tax efficiency.
27,199 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Oil market swings in early 2026 pushed Exxon Mobil and ConocoPhillips to diverging paths. This piece analyzes who is ...
SoFi Technologies is not your average fintech. This article explores how customer growth, cross-sell momentum, and pr...
Hasbro stock jumped today after a stronger quarter and higher guidance. This guide explains the earnings drivers, wha...
Navitas Semiconductor sits at the crossroads of faster charging and smarter energy use. This article maps possible pa...
A pro-Ripple lawyer’s critique of a potential Sam Bankman-Fried pardon is shaping XRP traders’ views as price targets...
In a volatile AI market, SoundHound AI posts a narrower loss for Q4 2025 and lifts 2025 revenue guidance, underscorin...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
A new alliance between Shopify and Google AI is reshaping e-commerce search and discovery. This analysis breaks down ...
Jim Cramer declares Broadcom undervalued after a solid earnings quarter with AI revenue accelerating; investors weigh...
Netflix faces a crossroads: expand by merging with major studios or double down on core strengths. This piece argues ...
Blend Labs reports a profitable fourth quarter as a rebound in mortgage activity boosts revenue and renews optimism f...